For May 2018, we have selected: Kappos L, Bar-Or A, Cree BAC, et al., for the EXPAND Clinical Investigators. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomized, phase 3 study. Lancet Neurol 2018;391:1263-1273. Secondary progressive multiple sclerosis (SPMS) is characterized by a previous history of relapsing remitting MS (RRMS) and the continuous progression of disability over the years typically without relapses.

Portugal is a country with a 900-year history: many remnants of past colonization by Celtics, Romans, and Arabians are still present. Unquestionably, the greater contribution of Portugal to the humanity have been the overseas navigations around the world, namely the discovery of the maritime way to India, the discovery of Brazil and of several Atlantic islands.

Please find below articles from French authors and co-authors that were published in the European Journal of Neurology

TEST YOURSELF ACROSS THE NEUROLOGY CURRICULUM – ENTIRELY FREE FOR EAN MEMBERS Whether you are a trainee preparing for your exit exam, or a specialist looking for objective feedback on your knowledge, this online self-assessment exercise will be open from… Continue Reading

The new CME article April 2018: “Clinical usefulness of prognostic biomarkers in optic neuritis” is online now! Please log-in and browse to the LEARN section on the EAN Website and answer the questions! All e-learning activities are free-of-charge for EAN… Continue Reading

Education is one of the key elements of the activities of the European Academy of Neurology. While the congress is well known to most of our members and European Neurologists the activities outside the congress are much less known. EAN has a special committee working on education[1] with Prof. Hannah Cock as the chair and the teaching course subcommittee under the leadership of Prof. Claudia Sommer. They are charged to develop an educational program including education for neurologists in training and advanced courses with the emphasis on training for the general neurologist. While the field of Neurology is getting increasingly broader it is of paramount importance to set a common ground for all neurologists which our education committee has carefully developed. For the congress educational programme, a five-year curriculum of the educational content covering all relevant topics has been developed over the past 3 years and parts of this plan are also applied to the educational activities outside the congress.

Prof. Wolfgang Oertel (WO): Dear Prof. Di Luca I congratulate you with your new position and kindly ask you to illustrate your plans for EBC’s strategy and work in the years to come. Prof. Monica Di Luca (MDL): Being elected as President of EBC is a great honour for me as well as an important challenge. This is an important era for EBC. Thanks to the excellent work of the past President David Nutt, the last 4 years witnessed the consolidation of our Council in the European scenario as the ideal platform where all voices related to brain research could find an interlocutor and could merge. We are now in the privileged position to start new projects and bring EBC to a next step.

  Founded/Established in and Short synopsis of aims and objectives The European ME Alliance (EMEA) was founded in 2008 and is committed to increase understanding of Myalgic
Encephalomyelitis (ME or ME/CFS) and improve quality of life experienced by people with… Continue Reading

Become a member of the Resident and Research Fellow Section of the European Academy of Neurology (EAN-RRFS) and gain access to exclusive member benefits.

Two years ago, the European Academy of Neurology – Residents and Research Fellows Section (EAN-RRFS) started a new initiative called “junior national representatives network” to establish a team of junior national representatives within the EAN-RRFS. The main aim is to enable closer links between the European countries in order to facilitate the speed of information flow, exchange experiences, and learn from each other.

          by Anna Sauerbier       1) EFNA launch ‘Survey of Young Europeans with Neurological Conditions’ http://www.braincouncil.eu/activities/news/efna-launch-survey-of-young-europeans-with-neurological-conditions/   2) Europe’s pharma companies join with non-profit group in push to measure outcomes of medical treatments https://sciencebusiness.net/healthy-measures/news/europes-pharma-companies-join-non-profit-group-push-measure-outcomes-medical… Continue Reading